Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study

In this study, we explored the predictive value of serum microRNA (miRNA) expression for early tumor progression during FOLFIRINOX chemotherapy and its association with overall survival (OS) in patients with pancreatic ductal adenocarcinoma (PDAC). A total of 132 PDAC patients of all disease stages...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Sijde, Fleur, Homs, Marjolein Y. V., van Bekkum, Marlies L., van den Bosch, Thierry P. P., Bosscha, Koop, Besselink, Marc G., Bonsing, Bert A., de Groot, Jan Willem B., Karsten, Thomas M., Groot Koerkamp, Bas, Haberkorn, Brigitte C. M., Luelmo, Saskia A. C., Mekenkamp, Leonie J. M., Mustafa, Dana A. M., Wilmink, Johanna W., van Eijck, Casper H. J., Vietsch, Eveline E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535910/
https://www.ncbi.nlm.nih.gov/pubmed/34681562
http://dx.doi.org/10.3390/ijms222010902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535910/
https://www.ncbi.nlm.nih.gov/pubmed/34681562
http://dx.doi.org/10.3390/ijms222010902

Ejemplares similares